Sandra Levy
ARTICLES BY THIS AUTHOR
- 5/3/2020
Hikma debuts generic Buprenex
Buprenorphine hydrochloride injection, had a market value of approximately $16 million for the 12 months ended February 2020, according to IQVIA. - 4/30/2020
Schnucks awards 2nd bonus to front-line employees
Schnucks is awarding a second cash bonus to employees during the COVID-19 pandemic as it also works to aid the community impacted by the virus. - 4/30/2020
CVS Health provides nearly $1.5M in grants to California nonprofits
CVS Health is providing nearly $1.5 million in grants to help four local nonprofit organizations in California expand access to telehealth services, to address food insecurity, and support the state’s paramedics and EMTs. - 4/30/2020
FDA OKs emergency use of Gilead's remdesivir for some COVID-19 cases
Gilead Sciences' remdesivir will be used to treat hospitalized patients with severe COVID-19. - 4/30/2020
Walgreens lowers prices on Prescription Savings Club meds
Walgreens has lowered prices on hundreds of medications available through its Prescription Savings Club, offering savings of up to 80% off its cash retail prices, as the program expands to welcome those with Medicare and Medicaid coverage. - 4/29/2020
AAM survey: Pharmaceutical shipping costs spiked due to pandemic
AAM's survey reveals a 224% hike, on average, in the cost of transporting drugs. - 4/29/2020
Innovation promotes 3 key executives
Innovation, a leader in high-volume automation technology and software, is elevating the role of three of its key executives. - 4/29/2020
CVS Health names chief communications officer
Kym White, CVS Health's newly appointed senior vice president and chief communications officer has more than 25 years of industry experience. - 4/29/2020
Schnucks sells grab-and-go meals from local restaurants
Schnucks Markets is helping local restaurants financially impacted by COVID-19 by selling their grab and go meals in its St. Louis-area stores. - 4/29/2020
FDA approves new indication for GlaxoSmithKline’s Zejula
GSK’s Zejula is the only oral monotherapy available as a first-line maintenance treatment for women regardless of BRCA mutational status, addressing a high unmet need in ovarian cancer.
